Skin care management in cancer patients: an evaluation of quality of life and tolerability.
about
The Hand-Foot Skin Reaction and Quality of Life Questionnaire: An Assessment Tool for OncologyBarrier protective use of skin care to prevent chemotherapy-induced cutaneous symptoms and to maintain quality of life in patients with breast cancer.Comparison between TEWL and laser scanning microscopy measurements for the in vivo characterization of the human epidermal barrier.Photobiomodulation for the management of radiation dermatitis: the DERMIS trial, a pilot study of MLS(®) laser therapy in breast cancer patients.Regorafenib-associated hand-foot skin reaction: practical advice on diagnosis, prevention, and management.A double-blind randomised controlled trial of a natural oil-based emulsion (Moogoo Udder Cream®) containing allantoin versus aqueous cream for managing radiation-induced skin reactions in patients with cancer.Xerosis and pruritus as major EGFRI-associated adverse events.Daily baseline skin care in the prevention, treatment, and supportive care of skin toxicity in oncology patients: recommendations from a multinational expert panel.Algorithm for dermocosmetic use in the management of cutaneous side-effects associated with targeted therapy in oncology.Living with the Effects of Cutaneous Toxicities Induced by Treatment.Efficacy of a global supportive skin care programme with hydrotherapy after non-metastatic breast cancer treatment: A randomised, controlled study.The relationship between psychosocial problems including depression and behavioural trends among middle-aged menopausal women in a cohort study.The impact of dermatological toxicities of anti-cancer therapy on the dermatological quality of life of cancer patients.Quantitative changes in skin composition parameters due to chemotherapy in breast cancer patients: a cohort study.
P2860
Q30279166-3A616A27-E29A-4A0C-A270-15DAEAF94B53Q30317153-E01DE339-8C69-4EB5-8454-A952A8A110CBQ34064048-CB4AA1AE-12DE-4651-ADAE-21E61ED7498CQ35999596-33F524D3-849D-4624-A185-480036F7188EQ36078348-D24D4C05-2D11-40CF-AC86-2FFC215F8A10Q36164303-18CFBEDE-1534-492E-B49E-590BA4844D0DQ36400206-EF493F53-7638-467B-A0A2-2F4D2397AA50Q37390753-5DBAC7FE-604F-466D-97F1-C85A214C9E62Q37442683-8818CBBA-1D67-453A-9920-4CE02DB1198FQ39427443-C166B1A9-D39A-4C45-BB01-01649990C9FEQ48190639-9F49158A-36A7-46D6-9EDE-3F9B10A4C0B8Q48445524-E2B50D6E-2773-405E-A0AE-21FF8AF526F6Q48483314-D25BFAC5-6911-41D2-9910-D2D6AD193B2CQ51838860-3FDE9222-C2DC-46C5-9C6B-9656EE655330
P2860
Skin care management in cancer patients: an evaluation of quality of life and tolerability.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Skin care management in cancer ...... lity of life and tolerability.
@ast
Skin care management in cancer ...... lity of life and tolerability.
@en
Skin care management in cancer ...... lity of life and tolerability.
@nl
type
label
Skin care management in cancer ...... lity of life and tolerability.
@ast
Skin care management in cancer ...... lity of life and tolerability.
@en
Skin care management in cancer ...... lity of life and tolerability.
@nl
prefLabel
Skin care management in cancer ...... lity of life and tolerability.
@ast
Skin care management in cancer ...... lity of life and tolerability.
@en
Skin care management in cancer ...... lity of life and tolerability.
@nl
P2093
P2860
P1476
Skin care management in cancer ...... lity of life and tolerability.
@en
P2093
Alfred Rademaker
Ann Cameron Haley
Cara Calahan
Mona Gandhi
P2860
P2888
P304
P356
10.1007/S00520-010-0851-8
P577
2010-03-25T00:00:00Z